Dimethylamine

Dimethylamine

SCHEMBL9702713

CCN(C)C(=O)C(=O)O.CNC

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL9701597 0.98
SCHEMBL209469 0.92
Diethylamine SCHEMBL9701558 0.86 TP53 (0.36)
Dimethylamine SCHEMBL9700399 0.81 EPHX2 (0.35)
SCHEMBL17704771 0.78 CHRM1 (0.36) FFAR3
SCHEMBL43188 0.75
Methylethylamine SCHEMBL10885397 0.75 NPC1 (0.33) FFAR3
SCHEMBL27796393 0.75
Dimethylamine SCHEMBL9700323 0.75 MEN1 (0.34)
Bromide SCHEMBL11752206 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5132454-A Antihypoxic agents MEIJI SEIKA KAISHA, LTD. (JP) 1992-07-21 US disclosed
US-5066677-A Antihypoxic agents, treatment of disorders resulting from reduced oxygen supply to brain MEIJI SEIKA KAISHA, LTD. (JP) 1991-11-19 US disclosed
EP-0387074-A2 Novel oxamic acid compounds and pharmaceutical composition for use in improvement of damaged cerebral functions of brain MEIJI SEIKA KAISHA LTD. (JP) 1990-09-12 EP disclosed